Trials / Recruiting
RecruitingNCT05970237
A Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2 Diabetes Mellitus and Hypertension
A Multicenter, Prospective, Non-interventional, Observational Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2 Diabetes Mellitus and Hypertension
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 9,000 (estimated)
- Sponsor
- Boryung Pharmaceutical Co., Ltd · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical trial is to evaluate the efficacy and safety of dapagliflozin in patient with type 2 diabetes mellitus and hypertension
Conditions
Timeline
- Start date
- 2023-07-26
- Primary completion
- 2025-10-21
- Completion
- 2025-10-21
- First posted
- 2023-08-01
- Last updated
- 2025-09-15
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05970237. Inclusion in this directory is not an endorsement.